background
manag
children
communityacquir
pneumonia
cap
larg
influenc
develop
new
molecular
diagnost
test
allow
simultan
detect
wide
rang
pathogen
object
evalu
diagnost
approach
includ
multiplex
pcr
assay
revisit
epidemiolog
etiolog
cap
children
hospit
studi
design
children
age
consult
emerg
depart
univers
hospit
saintetienn
franc
winter
period
includ
addit
bacteri
cultur
follow
pathogen
detect
use
biplex
commerciallyavail
rtpcr
test
adenoviru
respiratori
syncyti
viru
human
metapneumoviru
bocaviru
rhinovirusenteroviru
coronaviru
influenza
virus
b
parainfluenza
virus
mycoplasma
pneumonia
chlamydophila
pneumonia
result
patient
cap
least
one
pathogen
identifi
case
includ
bacteri
exclus
infect
viral
exclus
infect
mix
infect
coinfect
least
two
virus
observ
case
mean
age
higher
case
document
bacteri
infect
p
subgroup
viral
exclus
infect
mean
age
sever
case
year
vs
year
mild
moder
case
p
conclus
find
highlight
huge
proport
cap
viral
origin
high
number
coinfect
multipl
virus
low
number
bacteri
cap
notabl
children
year
address
need
reevalu
indic
empir
antimicrobi
treatment
age
group
communityacquir
pneumonia
cap
lead
caus
death
children
five
year
age
world
develop
countri
systemat
prescript
antimicrobi
drug
patient
cap
led
dramat
reduct
mortal
link
patholog
howev
bacteri
origin
cap
document
larg
proport
case
despit
extens
aetiolog
investig
current
recommend
encourag
pediatrician
prescrib
probabilist
antimicrobi
treatment
even
bacteri
infect
document
result
prolong
use
antibiot
possibl
select
resist
strain
within
endogen
flora
begin
current
centuri
absenc
document
bacteri
infect
attribut
difficulti
obtain
deep
respiratori
specimen
contamin
bacteria
local
flora
togeth
lower
sensit
blood
cultur
prove
bacteri
sepsi
time
epidemiolog
data
pediatr
cap
reli
tradit
bacteriolog
cultur
occurr
new
diagnost
tool
notabl
multiplex
pcr
assay
abl
simultan
detect
larg
panel
virus
atyp
bacteria
appear
larg
proport
cap
could
relat
viral
infect
mani
studi
evalu
new
tool
limit
subgroup
children
notabl
young
hospit
children
select
pathogen
aim
present
studi
document
presenc
larg
varieti
pathogen
respiratori
specimen
children
attend
pediatr
emerg
depart
univers
hospit
saintetienn
franc
sixmonth
period
present
cap
base
clinic
radiolog
evid
microbiolog
diagnost
approach
combin
bacteri
cultur
biplex
commerci
avail
rtpcr
test
detect
wide
rang
respiratori
pathogen
singl
center
epidemiolog
observ
studi
conduct
sixmonth
period
novemb
april
children
age
one
month
year
present
cap
pediatr
emerg
depart
univers
hospit
saintetienn
franc
studi
submit
approv
local
ethic
committe
oral
inform
given
togeth
form
explain
content
research
consent
form
sign
parent
legal
tutor
inclus
patient
cap
case
defin
subject
fever
least
c
agecorrect
polypnea
chest
radiograph
show
imag
acut
pneumonia
confirm
second
examin
pediatr
radiologist
ambulatori
children
pediatrician
hospit
patient
subject
exclud
second
read
notabl
case
associ
bronchiol
data
collect
inclus
compris
demograph
characterist
child
vaccin
statu
smoke
habit
parent
date
begin
current
respiratori
episod
drug
includ
antimicrobi
receiv
period
accord
current
guidelin
pneumonia
defin
sever
studi
patient
present
least
one
follow
criteria
respiratori
rate
per
minut
infant
less
year
age
per
minut
older
children
tachycardia
adjust
age
capillari
refil
time
oxygen
satur
control
visit
systemat
carri
day
either
phone
call
ambulatorytr
children
physic
examin
servic
hospit
children
admit
hospit
number
biolog
paramet
record
systemat
includ
c
reactiv
protein
crp
procalcitonin
pct
white
blood
cell
count
natremia
nasopharyng
secret
obtain
sputum
induct
sampl
entri
particip
follow
test
perform
inclus
standard
detect
convent
bacteria
cultur
detect
five
differ
virus
respiratori
syncyti
viru
rsv
influenza
virus
b
parainfluenza
virus
metapneumoviru
adenoviru
indirect
immunofluoresc
ifi
assay
detect
atyp
bacteria
pcr
previous
describ
parallel
blood
cultur
pneumococc
antigenuria
test
prescrib
clinician
notabl
case
hospit
addit
test
list
perform
time
hospit
attend
rtpcr
assay
perform
end
studi
aliquot
fraction
kept
frozen
c
whole
panel
nasopharyng
aspir
previous
describ
briefli
l
aspir
extract
nuclisen
easymag
tm
marci
letoil
franc
respiratori
multi
well
system
mw
rgene
tm
chlamyco
pneumo
influenza
ab
rsvhmpv
adhbov
hcovhpiv
rhino
evcc
use
molecular
test
consist
seri
biplex
assay
detect
either
coupl
pathogen
singl
pathogen
cell
control
cc
attest
presenc
cellular
nucleic
acid
within
specimen
follow
pathogen
test
mycoplasma
pneumonia
chlamydophila
pneumonia
influenza
virus
b
rsv
human
metapneumoviru
hmpv
adenoviru
adv
bocaviru
bov
parainfluenza
virus
coronavirus
rhinovirusenteroviru
hrev
cell
control
univari
analysi
perform
compar
case
document
probabl
relat
bacteri
infect
threshold
cfuml
convent
cultur
presenc
atyp
bacterium
pcr
nasopharyng
aspir
other
comparison
adjust
age
sever
pneumonia
monomultipl
infect
also
perform
chisquar
test
fisher
exact
test
use
compar
qualit
variabl
wherea
student
test
use
quantit
variabl
p
valu
consid
statist
signific
multivari
analysi
factor
independ
associ
detect
bacteri
secondarili
perform
paramet
includ
logist
regress
model
p
univari
analysi
sixmonth
period
studi
children
thought
cap
includ
exclud
secondarili
compris
case
noncap
infect
case
without
nasopharyng
aspir
one
case
cap
whose
inclus
consent
child
famili
refer
total
number
case
cap
record
period
pediatr
emerg
depart
n
represent
rate
demograph
clinic
characterist
includ
case
togeth
mode
manag
ambulatori
hospit
probabilist
antimicrobi
treatment
list
tabl
apyrexia
observ
case
day
respect
children
hospit
entri
still
hospit
day
respect
one
child
need
intens
care
within
pediatr
intens
care
unit
antimicrobi
treatment
modifi
three
case
neither
fatal
case
immedi
sequela
observ
studi
twentysix
case
classifi
sever
cap
gener
biolog
characterist
includ
case
follow
median
count
leukocyt
per
liter
interquartil
rang
neutrophil
crp
median
rate
mgl
interquartil
rang
pct
median
rate
gl
interquartil
rang
hyponatremia
meql
observ
case
use
ifi
prospect
nasopharyng
aspir
found
posit
includ
rsv
adv
influenzaviru
b
infect
confirm
retrospect
rtpcr
assay
pneumococc
antigenuria
avail
case
posit
patient
exhibit
threshold
cfuml
convent
cultur
three
pneumococc
infect
antigenuria
avail
blood
cultur
perform
case
found
posit
streptococcu
pneumonia
one
case
combin
bacteri
cultur
retrospect
rtpcr
assay
least
one
pathogen
identifi
case
number
detect
pathogen
tabl
case
cap
bacteri
exclus
infect
observ
infect
least
one
bacterium
one
viru
viral
exclus
infect
coinfect
least
two
virus
observ
case
tabl
display
distribut
identifi
pathogen
specifi
variou
associ
common
advrsv
case
haemophilu
influenzaeadv
case
hrevbov
case
monthli
distribut
microbiolog
infect
depict
fig
shown
tabl
none
variabl
test
statist
correl
presenc
bacteri
pathogen
univari
analysi
except
age
higher
case
document
bacteri
infect
mean
age
vs
year
p
student
test
presenc
abdomin
pain
clinic
examin
entri
p
concern
biolog
paramet
correl
observ
bacteri
nonbacteri
case
notabl
crp
pct
except
white
blood
cell
count
higher
case
viral
infect
sever
statist
associ
neither
bacteri
non
bacteri
etiolog
cap
younger
age
except
subgroup
viral
exclus
infect
n
mean
age
sever
case
year
vs
year
mild
moder
case
p
student
test
coinfect
associ
younger
age
sever
diseas
even
number
detect
pathogen
tend
relat
sever
cap
infect
agent
sever
case
vs
nonsever
case
p
student
test
multivari
analysi
none
test
variabl
independ
associ
bacteri
infect
demograph
characterist
includ
patient
coher
literatur
term
age
median
age
year
interquartil
rang
year
sex
ratio
benefit
male
patient
cap
shown
exhibit
differ
risk
factor
illustr
lower
vaccin
coverag
compar
french
popul
elev
rate
previou
hospit
histori
frequent
respiratori
diseas
high
level
smoke
habit
parent
tabl
approxim
children
reach
hospit
without
consult
anoth
physician
alreadi
receiv
antipyret
treatment
mainli
acetaminophen
also
nonsteroid
antiinflammatori
drug
nsaid
despit
fact
use
nsaid
may
harm
entri
children
receiv
antimicrobi
treatment
case
first
choic
antimicrobi
drug
amoxicillin
current
recommend
despit
limit
size
present
studi
restrict
singl
center
origin
lie
divers
includ
tabl
detail
present
case
communityacquir
pneumonia
exhibit
infect
least
pathogen
gray
box
indic
total
number
posit
case
pathogen
white
box
correspond
case
coinfect
microbiolog
point
view
first
use
justifi
definit
level
detect
constitut
caus
agent
children
cap
includ
studi
concern
bacteri
load
threshold
cfuml
retain
recommend
european
expert
induc
sputum
specimen
use
help
discard
pneumococc
colon
preval
children
less
year
old
true
infect
contrast
asymptomat
carrier
state
virus
rather
uncommon
respiratori
virus
apart
post
activ
phase
respiratori
virosi
justifi
consid
detect
viral
genom
respiratori
specimen
marker
probabl
viral
infect
exhaust
studi
perform
earlier
percentag
elucid
case
microbiolog
point
view
rang
wherea
present
studi
detect
wide
spectrum
infecti
agent
respiratori
tropism
report
earlier
viral
infect
shown
predomin
children
year
age
cap
found
bacteri
origin
eighteen
children
receiv
antimicrobi
therapi
emerg
consult
could
consid
sourc
falseneg
cultur
howev
alway
symptomat
entri
impli
bacterium
present
signific
opportun
recov
cultur
interest
find
studi
larg
proport
viral
coinfect
much
higher
previous
report
notabl
bocaviru
metapneumoviru
adenoviru
detect
associ
least
one
viru
cap
case
involv
agent
tabl
suggest
infect
sever
virus
could
enhanc
sever
cap
present
studi
trend
observ
associ
mean
number
infecti
agent
sever
cap
defin
p
larger
effect
size
would
need
determin
statist
signific
differ
term
clinic
evolut
neither
death
major
complic
report
studi
despit
rate
sever
pneumonia
hospit
statist
differ
sever
cap
viral
bacteri
infect
almost
children
receiv
antibiot
unnecessari
larg
proport
case
virus
detect
find
rais
question
systemat
use
antimicrobi
treat
childhood
cap
still
recommend
differ
guidelin
present
find
togeth
other
allow
identif
subpopul
children
less
year
age
mild
moder
symptom
viral
etiolog
cap
highli
probabl
situat
repres
half
case
record
studi
children
less
fiveyear
old
present
mild
moder
cap
correspond
case
use
rapid
molecular
test
detect
larg
set
viral
bacteri
pathogen
within
hour
describ
would
allow
improv
manag
antimicrobi
treatment
case
posit
result
would
recommend
avoid
use
amoxicillin
firstint
therapi
prescrib
erythromycin
case
detect
agent
atyp
pneumonia
reconsid
use
antimicrobi
treatment
h
later
accord
clinic
evolut
result
bacteri
cultur
convers
neg
rapid
test
would
lead
empir
prescript
amoxicillin
current
recommend
obviou
attitud
would
dedic
cap
mild
moder
symptom
cap
sever
present
entri
includ
systemat
probabilist
antimicrobi
therapi
whatev
result
pcr
assay
present
result
indic
strategi
could
dramat
reduc
proport
unnecessari
antimicrobi
treatment
mild
moder
child
cap
wider
studi
need
prospect
evalu
benefit
approach
term
patient
recoveri
prevent
antibiot
resist
medic
economi
reagent
use
retrospect
analysi
fund
grant
medic
associ
pediatrician
univers
hospit
saintetienn
research
studi
aderp
franc
medic
associ
paediatrician
universityhospit
saintetienn
research
studi
aderp
